Japan-Thailand Research Collaboration Centre on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan; Department of Bacterial Infections, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Japan-Thailand Research Collaboration Centre on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan; Department of Bacteriology Ⅰ, National Institute of Infectious Diseases, Tokyo, Japan.
Int J Antimicrob Agents. 2022 Oct;60(4):106644. doi: 10.1016/j.ijantimicag.2022.106644. Epub 2022 Jul 28.
Heteroresistance is the phenomenon wherein subpopulations of presumed isogenic bacteria show varied antibiotic susceptibilities, and the current gold standard for the determination of heteroresistance is population analysis profiling (PAP). However, when conducting PAP to confirm carbapenem heteroresistance in Enterobacteriaceae, the authors found some isolates that did not seem to be heteroresistant, despite meeting PAP criteria. This article elaborates on the validity of PAP for the determination of heteroresistance, especially among carbapenemase-producing Enterobacteriaceae (CPE). Bacterial cells that were originally non-viable on selective agar supplemented with a high concentration of meropenem were found to be occasionally viable, likely due to the hydrolysis of carbapenems by carbapenemases produced by dying cells, mimicking the emergence of subpopulations with enhanced resistance. As such, PAP for CPE is highly affected by carbapenemases produced by dying populations, and may not detect heterogeneity in carbapenem resistance appropriately among seemingly isogenic clones.
异质性耐药是指假定同基因细菌的亚群表现出不同的抗生素敏感性的现象,目前用于确定异质性耐药的金标准是群体分析分析(PAP)。然而,当进行 PAP 以确认肠杆菌科中的碳青霉烯异质性耐药时,作者发现一些分离株似乎没有异质性耐药,尽管符合 PAP 标准。本文详细阐述了 PAP 用于确定异质性耐药的有效性,特别是在产碳青霉烯酶的肠杆菌科(CPE)中。在补充了高浓度美罗培南的选择性琼脂上最初无法存活的细菌细胞偶尔会变得存活,这可能是由于垂死细胞产生的碳青霉烯酶水解碳青霉烯,模拟了具有增强耐药性的亚群的出现。因此,针对 CPE 的 PAP 受到垂死群体产生的碳青霉烯酶的高度影响,并且可能无法在看似同基因克隆中适当检测到碳青霉烯耐药性的异质性。